Foghorn Therapeutics (FHTX) Prepaid Assets (2019 - 2026)
Foghorn Therapeutics' (FHTX) quarterly Prepaid Assets came in at $3.2 million in Q1 2026, down 34.09% year-on-year from $4.8 million in Q1 2025, and up 2.98% quarter-over-quarter from $3.1 million in Q4 2025.
Foghorn Therapeutics (FHTX) Prepaid Assets (2019 - 2026) Analysis & Trends
Foghorn Therapeutics' Prepaid Assets history runs 8 years deep, the most recent figure standing at $3.2 million for Q1 2026.
- On a quarterly basis, Prepaid Assets fell 34.09% year-over-year to $3.2 million in Q1 2026; TTM through Mar 2026 was $3.2 million, a 34.09% decrease from a year earlier, with the FY2025 full-year figure at $3.1 million, down 47.2% from the prior year.
- Prepaid Assets improved to $3.2 million in Q1 2026 per FHTX's latest filing, from $3.1 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $6.2 million in Q2 2023 and bottomed at $2.6 million in Q3 2025.
- The 5-year median for Prepaid Assets is $4.8 million (2025), against an average of $4.7 million.
- Across the five-year window, Prepaid Assets surged 57.02% in 2022 and sank 47.2% in 2025, its largest moves.
- Year by year, Prepaid Assets stood at $5.6 million in 2022, then increased by 9.34% to $6.1 million in 2023, then declined by 4.41% to $5.9 million in 2024, then sank by 47.2% to $3.1 million in 2025, then gained by 2.98% to $3.2 million in 2026.
- Per Business Quant, the three latest FHTX Prepaid Assets figures stand at $3.2 million (Q1 2026), $3.1 million (Q4 2025), and $2.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Foghorn Therapeutics | 352.57 Mn | 263.66 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.18 Mn |
| Dec 31, 2025 | 3.09 Mn |
| Sep 30, 2025 | 2.59 Mn |
| Jun 30, 2025 | 3.93 Mn |
| Mar 31, 2025 | 4.83 Mn |
| Dec 31, 2024 | 5.85 Mn |
| Sep 30, 2024 | 3.84 Mn |
| Jun 30, 2024 | 4.44 Mn |
| Mar 31, 2024 | 4.86 Mn |
| Dec 31, 2023 | 6.12 Mn |
| Sep 30, 2023 | 5.55 Mn |
| Jun 30, 2023 | 6.18 Mn |
| Mar 31, 2023 | 4.73 Mn |
| Dec 31, 2022 | 5.60 Mn |
| Sep 30, 2022 | 4.24 Mn |
| Jun 30, 2022 | 5.34 Mn |
| Mar 31, 2022 | 5.09 Mn |
| Dec 31, 2021 | 5.27 Mn |
| Sep 30, 2021 | 3.11 Mn |
| Jun 30, 2021 | 3.40 Mn |